CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Clearside Biomedical, Inc. - CLSD CFD

0.9222
0%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0105
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.9222
Open 0.9312
1-Year Change -34.76%
Day's Range 0.9222 - 0.9322
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 16, 2025 0.9222 -0.0150 -1.60% 0.9372 0.9522 0.9044
Jan 15, 2025 0.9272 0.0200 2.20% 0.9072 0.9361 0.8982
Jan 14, 2025 0.9022 -0.0250 -2.70% 0.9272 0.9272 0.8972
Jan 13, 2025 0.9224 -0.0248 -2.62% 0.9472 0.9472 0.9172
Jan 10, 2025 0.9712 0.0031 0.32% 0.9681 0.9772 0.9472
Jan 8, 2025 0.9622 -0.0350 -3.51% 0.9972 0.9972 0.9562
Jan 7, 2025 0.9682 -0.0216 -2.18% 0.9898 0.9972 0.9672
Jan 6, 2025 0.9873 0.0171 1.76% 0.9702 0.9972 0.9672
Jan 3, 2025 0.9573 0.0197 2.10% 0.9376 0.9616 0.9372
Jan 2, 2025 0.9405 -0.0167 -1.74% 0.9572 0.9579 0.9248
Dec 31, 2024 0.9391 -0.0481 -4.87% 0.9872 0.9944 0.9371
Dec 30, 2024 0.9873 0.0251 2.61% 0.9622 1.0072 0.9622
Dec 27, 2024 0.9374 0.0102 1.10% 0.9272 0.9672 0.9272
Dec 26, 2024 0.9260 0.0288 3.21% 0.8972 0.9389 0.8772
Dec 24, 2024 0.9017 0.0276 3.16% 0.8741 0.9274 0.8472
Dec 23, 2024 0.8767 -0.0105 -1.18% 0.8872 0.9073 0.8372
Dec 20, 2024 0.8649 -0.0523 -5.70% 0.9172 0.9172 0.7972
Dec 19, 2024 0.9272 -0.0500 -5.12% 0.9772 0.9872 0.9212
Dec 18, 2024 0.9872 0.0000 0.00% 0.9872 1.0072 0.9672
Dec 17, 2024 1.0072 -0.0100 -0.98% 1.0172 1.0272 0.9872

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Clearside Biomedical, Inc. Company profile

About Clearside Biomedical Inc

Clearside Biomedical, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Its proprietary suprachoroidal space (SCS) microinjector targeting SCS offers access to the macula, retina and choroid where sight-threatening disease often occurs. The SCS injection platform is an inherently flexible, in-office, non-surgical procedure intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations. The Company’s suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye through SCS. The Company’s lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Clearside Biomedical Inc revenues increased from $7.9M to $29.6M. Net income totaled $376K vs. loss of $18.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other expense decrease from $275K (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to $0.01.

Industry: Bio Therapeutic Drugs

900 North Point Parkway
Suite 200
ALPHARETTA
GEORGIA 30005
US

People also watch

ETH/USD

3,482.72 Price
+4.820% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

XRP/USD

3.24 Price
-2.090% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01618

US100

21,441.70 Price
+1.820% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading